Red Wave Investments’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-5,509
Closed -$280K 121
2025
Q4
$280K Sell
5,509
-247
-4% -$12.6K 0.08% 90
2025
Q3
$319K Sell
5,756
-200
-3% -$11.7K 0.1% 79
2025
Q2
$411K Buy
5,956
+64
+1% +$4.35K 0.14% 66
2025
Q1
$409K Sell
5,892
-50
-0.8% -$4.13K 0.15% 65
2024
Q4
$511K Buy
5,942
+15
+0.3% +$1.62K 0.18% 55
2024
Q3
$706K Sell
5,927
-69
-1% -$9.2K 0.25% 50
2024
Q2
$856K Sell
5,996
-90
-1% -$11.9K 0.32% 44
2024
Q1
$781K Buy
6,086
+16
+0.3% +$1.91K 0.29% 45
2023
Q4
$628K Sell
6,070
-51
-0.8% -$5.04K 0.25% 50
2023
Q3
$557K Sell
6,121
-15
-0.2% -$1.32K 0.24% 55
2023
Q2
$496K Buy
6,136
+138
+2% +$11.3K 0.2% 56
2023
Q1
$477K Buy
5,998
+152
+3% +$10.8K 0.2% 55
2022
Q4
$396K Sell
5,846
-2,770
-32% -$162K 0.17% 59
2022
Q3
$429K Buy
8,616
+12
+0.1% +$643 0.19% 61
2022
Q2
$479K Sell
8,604
-574
-6% -$31.9K 0.2% 58
2022
Q1
$510K Buy
9,178
+2,356
+35% +$121K 0.18% 60
2021
Q4
$382K Buy
6,822
+400
+6% +$21.7K 0.13% 65
2021
Q3
$308K Buy
6,422
+70
+1% +$3.38K 0.11% 71
2021
Q2
$266K Buy
6,352
+110
+2% +$4.26K 0.1% 76
2021
Q1
$210K Buy
+6,242
New +$222K 0.09% 84

Other funds holding NVO

Red Wave Investments's NVO Position: Q1 2026 in Review

Red Wave Investments sold out of Novo Nordisk (NVO) in Q1 2026, closing a stake of 5,509 shares — an estimated $280K sold.

Red Wave Investments first reported a position in NVO in Q1 2021 and held it in 20 quarters. The position peaked at $856K in Q2 2024. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Red Wave Investments reported no remaining Novo Nordisk position as of Q1 2026 after selling out during the quarter.
  • Red Wave Investments sold 5,509 Novo Nordisk shares in Q1 2026, an estimated $280K.
  • Red Wave Investments first reported a position in Novo Nordisk in Q1 2021 and held it in 20 quarters.
  • Red Wave Investments's Novo Nordisk position peaked at $856K in Q2 2024.
  • 1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Red Wave Investments's 13F filing for Q1 2026, filed 8 May 2026.